Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleA billion dollar punt.AbstractMerck's acquisition of Sirna Therapeutics is a gamble, but gambling may not always be such a bad thing.SubjectsPHARMACEUTICAL industry mergers; BIOTECHNOLOGY industries; SIRNA Therapeutics Inc.; RETINAL degeneration; MERCK &; Co. Inc.; RIBOZYME Pharmaceuticals Inc.PublicationNature Biotechnology, 2006, Vol 24, Issue 12, p1453ISSN1087-0156Publication typeEditorialDOI10.1038/nbt1206-1453